Skip to content

Pharminent

cropped-ChatGPT-Image-May-20-2026-08_10_54-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • AZ, Amgen will pilot FDA’s real-time clinical trial plan
  • Regulatory

AZ, Amgen will pilot FDA’s real-time clinical trial plan

Pharmaphorum

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

Read full story

pharminent April 29, 2026 (Last updated: April 29, 2026)

Pharmaphorum

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questions
Next: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031

Related Stories

  • Regulatory

Bayer gets swift review for Kerendia in type 1 diabetes

pharminent May 21, 2026
  • Regulatory

Pazdur declines to announce candidacy for vacated FDA commissioner role

pharminent May 20, 2026
  • Regulatory

VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

pharminent May 19, 2026

You May Have Missed

  • M&A / Deals

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay

pharminent May 26, 2026
  • Clinical Data

Lilly’s Verve gambit pays off as base editor cuts cholesterol in early study

pharminent May 26, 2026
  • Other

All eyes on Revolution, bispecific antibodies and more at ASCO26

pharminent May 26, 2026
wp_feature_2026-05-22
  • News

pharminent May 23, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.